Figure 2From: Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort studyOverall survival (A), disease-free survival (B), death from breast cancer (C), and cumulative incidence of recurrence after a breast cancer diagnosis (D). Results are shown by tertiles of plasma C-reactive protein (CRP) and are based on 2,910 women from the Copenhagen Breast Cancer Study who were observed for up to seven years.Back to article page